IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.455%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

21 Dec 2017 10:16

RNS Number : 0645A
Baronsmead Second Venture Trust PLC
21 December 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

21 December 2017

Issue of New Shares pursuant to the Offer for Subscription

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (the "Offer").

The Company announced on 21 November 2017 that it had raised gross proceeds of approximately £21 million pursuant to the Offer and accordingly had issued 21,593,264 New Shares in aggregate under the Offer because of allotments that occurred on 26 October 2017, 17 November 2017 and 21 November 2017. Since then the Company has raised additional gross proceeds of approximately £2,119,000. Accordingly the Company has carried out a fourth allotment of New Shares pursuant to the Offer, issuing 2,160,004 New Shares in aggregate at an issue price of 98.10 pence. The issue price of the fourth allotment has been calculated by dividing the Company's latest published Net Asset Value of 95.07 pence as at 30 November 2017 by 0.97 in accordance with the pricing formula set out in the Prospectus.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 22 December 2017.

It is expected that share certificates and tax certificates in respect of the New Shares will be issued to the relevant Shareholders on or around 10 January 2018.

The Board announced on 24 November 2017 that the final allotment of New Shares pursuant to the Offer would take place on or around 20 December 2017 or earlier if the Offer became fully subscribed. The Company has raised gross proceeds of approximately £23,156,000 pursuant to the Offer and accordingly the directors have determined to close the Offer as at close of business on 20 December 2017.

Total voting rights

Each Ordinary Share has one voting right. Following the fourth allotment of New Shares pursuant to the Offer, the Company will have 232,791,189 Ordinary Shares in issue (of which 13,738,214 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 219,052,975 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAEAFAFAXFFF
Date   Source Headline
1st Aug 20231:54 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:25 amRNSTotal Voting Rights
20th Jun 20233:40 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
2nd May 202312:52 pmRNSTotal Voting Rights
5th Apr 20236:30 pmRNSTransaction in Own Shares
3rd Apr 20235:26 pmRNSTotal Voting Rights
3rd Apr 20233:49 pmRNSAllotment of Shares
3rd Apr 202311:11 amRNSTotal Voting Rights
30th Mar 202312:00 pmRNSNet Asset Value(s)
27th Mar 20235:23 pmRNSUpdate on Fundraising
14th Mar 20234:28 pmRNSAllotment of Shares
13th Mar 20235:44 pmRNSDirector/PDMR Shareholding
13th Mar 20235:43 pmRNSDirector/PDMR Shareholding
9th Mar 20236:25 pmRNSTransaction in Own Shares
9th Mar 20233:17 pmRNSUpdate on Fundraising
6th Mar 20234:45 pmRNSNet Asset Value(s)
1st Mar 20232:23 pmRNSTotal Voting Rights
24th Feb 20235:20 pmRNSUpdate on Fundraising
17th Feb 20236:16 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20235:00 pmRNSNet Asset Value(s)
1st Feb 20233:58 pmRNSDirector/PDMR Shareholding
1st Feb 20233:56 pmRNSResult of AGM
30th Jan 20235:38 pmRNSDirector/PDMR Shareholding
30th Jan 20235:36 pmRNSDirector/PDMR Shareholding
30th Jan 20233:05 pmRNSAllotment of Shares
27th Jan 202311:30 amRNSNet Asset Value(s)
3rd Jan 20234:50 pmRNSTotal Voting Rights
29th Dec 20224:56 pmRNSTransaction in Own Shares
16th Dec 202212:47 pmRNSPublication of a Prospectus
12th Dec 20224:45 pmRNSTransaction in Own Shares
6th Dec 20225:30 pmRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSAnnual Financial Report
7th Nov 202211:30 amRNSNet Asset Value(s)
1st Nov 202211:21 amRNSTotal Voting Rights
14th Oct 20226:16 pmRNSTransaction in Own Shares- Correction
14th Oct 20224:45 pmRNSNet Asset Value(s)
4th Oct 202211:57 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
29th Sep 20226:32 pmRNSTransaction in Own Shares
13th Sep 20226:03 pmRNSTransaction in Own Shares
6th Sep 20225:45 pmRNSNet Asset Value(s)
1st Sep 20225:49 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.